Oats

What it is

Oats are a whole grain, eaten as porridge (oatmeal), flakes, bran, or in bread, cookies and drinks. Their best-studied active fibre is beta-glucan, a soluble fibre that becomes thick and gel-like in the gut; how thick it gets depends on its molecular weight and how much dissolves [1]. Oats also provide protein, vitamins and minerals [2]. Trials have used about 3 g of beta-glucan a day, or 30 g of oat bran a day [3][4]. Some oat products are sold as gluten-free [5].

How it might work

Proposed: the thick gel that beta-glucan forms in the gut seems to be the key, because its effect on cholesterol and blood sugar depended on its viscosity in trials [1][6]. In one trial, the more viscous oat breakfast also slowed stomach emptying [6]. These are proposed mechanisms, not established ones.

What the research says

The strongest evidence is for LDL cholesterol. A 2014 meta-analysis of 28 randomised trials found that at least 3 g of oat beta-glucan a day lowered LDL by about 0.25 mmol/L compared with control diets, with no effect on HDL ("good") cholesterol or triglycerides [3]. A 2016 meta-analysis of 58 trials found a similar median fall of 0.19 mmol/L at 3.5 g a day, but the trials varied widely [7]. A 2022 meta-analysis of 13 trials in adults with high cholesterol found an LDL fall of 0.27 mmol/L [8]. In a 2021 double-blind trial of 191 adults with borderline high cholesterol, a daily drink with 3 g of oat beta-glucan lowered LDL by 0.21 mmol/L more than a rice-powder drink over four weeks [9]. Not every trial agrees: in a 2010 trial, low-molecular-weight oat beta-glucan did not significantly lower LDL, while high-molecular-weight forms did [1].

For blood sugar after a meal, a 2021 meta-analysis of 103 short crossover meal comparisons (538 people) found that adding oat beta-glucan reduced the extra blood sugar rise by about 23%, and that the effect grew with the dose [10]. In a 2020 crossover trial of 28 people, an oat-bran breakfast lowered the blood sugar and insulin rise compared with a rice-cereal breakfast [6].

Several small trials found that oats make people feel fuller. In a 2013 crossover trial of 48 people, an oatmeal breakfast with the same calories as a ready-to-eat cereal increased fullness and reduced hunger over four hours [11]. In 30 women, biscuits and juice enriched with 4 to 8 g of beta-glucan increased satiety [12]. In 33 people, 4 g of beta-glucan at breakfast increased fullness, but did not change how much they ate at a later meal [13]. A 2020 trial of 28 people found no difference in appetite compared with a rice-cereal breakfast [6].

For blood pressure, a 2023 meta-analysis of 21 trials (1,569 people) found systolic (top number) blood pressure about 2.8 mmHg lower after oats; the diastolic (bottom number) result was not statistically significant [14]. A 2026 meta-analysis of overweight and obese adults found about 1.4 mmHg lower systolic pressure [15]. In a 2021 trial of 50 people with high blood pressure, 30 g of oat bran a day lowered office blood pressure more than standard advice alone, and use of blood pressure medicine fell more in the oat group [4]. A 2025 crossover pilot of 21 people with mild hypertension found no change in blood pressure from 4 g of beta-glucan a day in oat cookies [16].

For weight, results are mixed. A 2019 meta-analysis of 20 trials of cereal beta-glucan found body weight about 0.77 kg lower [17], and a 2022 meta-analysis of oat supplements found about 0.94 kg lower [18]. But a 2026 meta-analysis of overweight and obese adults found no effect on body weight [15], and in a three-month trial of 66 overweight women on a calorie-reduced diet, adding beta-glucan did not increase weight loss [19].

For long-term blood sugar in type 2 diabetes, results are mixed. A 2016 meta-analysis of four trials (350 people with type 2 diabetes, 3 to 8 weeks) found HbA1c about 0.21 percentage points lower with 2.5 to 3.5 g of beta-glucan a day [20]. But a 16-week trial of 194 adults at risk of type 2 diabetes, eating bread with 6 g of beta-glucan a day, found no difference in HbA1c from whole-grain wheat bread [21]. A 2026 crossover trial of 60 adolescents with type 1 diabetes found lower HbA1c with oat flakes, but type 1 is a different condition [22].

Oats also changed gut bacteria in two small trials. In 63 people after weight-loss surgery, 30 g of oat bran a day for 12 weeks increased bacteria the authors describe as beneficial [23]; in the blood pressure trial above, the bacterial mix also changed [4]. These trials measured bacteria, not gut symptoms or disease. For bowel function, 102 g of oat bran a day increased stool volume in 24 adults [24], while 3.3 g of oat beta-glucan a day did not change stool frequency or stool weight in a 14-person trial [25].

On coeliac disease, the evidence does not agree. In a 2025 study of 29 people with coeliac disease, purified oat protein (avenin) caused acute symptoms in 17 (59%); one person vomited and had a wheat-like immune response [26]. In a 12-week challenge of 15 adults with coeliac disease eating 350 g of pure oats a week, symptoms and gut biopsies did not change [27]. A large cross-sectional study of 869 people with coeliac disease found no differences in symptoms or gut healing between oat eaters and non-eaters [28]. A 2012 review concluded that the risk from oats may be lower than first thought but depends on the oat strain [29].

Doses used in studies

LDL trials used at least 3 g of beta-glucan a day for two to twelve weeks [3]; the highest dose in that review was 12.4 g a day [3]. A beverage trial used 1 g three times a day for four weeks [9]. Blood sugar meal trials used single meals with about 4 g of beta-glucan, or 10 g of oat bran [6]. Blood pressure trials used 30 g of oat bran a day for three months [4]. The trial in people with type 2 diabetes risk used 6 g of beta-glucan a day for 16 weeks [21]. Coeliac challenge trials used 350 g of pure oats a week [27]. These are doses from trials, not recommendations.

Safety and interactions

Common side effects: the most common adverse events in a 2024 review of oat trials were digestive, mainly diarrhoea, nausea and wind (flatulence) [30]. In a 2021 trial, both the beta-glucan drink and the control drink caused temporary stomach symptoms, so these are not specific to oats [9]. Upper limits: no upper intake limit or toxic dose was found in the studies read; the highest beta-glucan dose in the LDL review was 12.4 g a day, and no major adverse events were reported in the 2021 drink trial [3][9]. Medicines: no study tested oats together with medicines. Oat beta-glucan slowed stomach emptying in one trial, so whether this changes how medicines are absorbed is unknown [6]. No study we found tested oats together with insulin or glucose-lowering medicines. Pregnancy and breastfeeding: no studies of oats or oat beta-glucan in pregnancy or breastfeeding were found. Kidney, liver and bleeding disorders: no studies of oats in people with these conditions were found.

Coeliac disease: oats are naturally gluten-free, but regular oats are often contaminated with other grains. A 2016 narrative review says regular oats sold in Canada are largely contaminated [31]. In a 2022 test of 25 gluten-free labelled oat products, gluten was above the local 5 ppm limit in 40% and above the Codex 20 ppm limit in 36% [5]. A 2019 review says oats are only recommended for coeliac patients in remission, and that some patients are at risk of an immune reaction to oats [2]. In a 2025 study, one of 29 people had a wheat-like immune response to oat protein, so a minority may need to avoid oats [26]. A 2018 analysis argued that gluten contamination in earlier oat trials could explain some adverse reactions [32].

Caveats and open questions

Most cholesterol, blood pressure and blood sugar results are surrogate markers. Few trials we read measured heart attacks, strokes or deaths; a 2024 review notes one study that did and found no significant difference in major cardiovascular events [30]. Form matters: many blood sugar trials used oat beta-glucan concentrate or oat bran added to test meals, not whole oats [10]. Most trials ran for two to sixteen weeks, so long-term effects are not established [3][21].

The results conflict in places: the LDL effect depends on beta-glucan molecular weight [1], the 2025 trial in at-risk adults found no HbA1c benefit [21], and the 2025 pilot found no blood pressure change [16].

Funding and ties: the authors of the 2021 blood sugar review report financial ties to several food and sugar industry groups [10]. Two authors of the 2022 cardiovascular review were employees of Standard Process Inc. [18]. The 2025 trial in at-risk adults was funded by public research councils, and its authors report supplies from a cereal company, Lantmännen Cerealia [21].

Coeliac evidence is small: the challenge studies had 15 and 29 people, and the largest study was observational [27][26][28]. Our search of ClinicalTrials.gov found no recruiting oat trials on these outcomes, so no ongoing trial is listed.